Evidence map›Paper›PMID 26648789›Full record

ArticleThrombosis journal2015

Global Thrombosis Test - a possible monitoring system for the effects and safety of dabigatran.

Kazunori Otsui, Diana A Gorog, Junichiro Yamamoto, Takayuki Yoshioka, Sachiyo Iwata, Atsushi Suzuki, Toru Ozawa, Asumi Takei, Nobutaka Inoue

Open access · goldAbstract read
In one paragraph

Article in Thrombosis journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Comparison of Shear Stress-Induced Thrombotic and Thrombolytic Effects Among 3 Different Antithrombotic Regimens in Patients With Acute Coronary Syndrome.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Trial
  2. Review
  3. Global Thrombosis Test: Occlusion Is Attributable to Shear-Induced Platelet Thrombus Formation.TH open : companion journal to thrombosis and haemostasis · 2021
    Article
  4. Global Thrombosis Test: Occlusion by Coagulation or SIPA?TH open : companion journal to thrombosis and haemostasis · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Kazunori OtsuiKobe Rosai Hospital, Kobe, Japan.
Diana A GorogImperial College, London, UK.
Junichiro YamamotoKobe Gakuin University, Kobe, Japan.
Takayuki YoshiokaKobe Rosai Hospital, Kobe, Japan.
Sachiyo IwataKobe Rosai Hospital, Kobe, Japan.
Atsushi SuzukiKobe Rosai Hospital, Kobe, Japan.
Toru OzawaKobe Rosai Hospital, Kobe, Japan.
Asumi TakeiKobe Rosai Hospital, Kobe, Japan.
Nobutaka InoueKobe Rosai Hospital, Kobe, Japan ; Department of Cardiovascular Medicine, Kobe Rosai Hospital, 4-1-23, Kagoike Touri, Chuo-Ku, Kobe, 651-0053 Japan.
Kobe Rosai Hospital · JPImperial College London · GBKobe Gakuin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDabigatran is an alternative to warfarin (WF) for the thromboprophylaxis of stroke in patients with non-valvular atrial fibrillation (NVAF). The advantage of dabigatran over WF is that monitoring is not required; however, a method to monitor the effect and the safety of dabigatran is not currently available. The Global Thrombosis Test (GTT) is a novel method to assess both clot formation and lysis activities under physiological conditions.

objectiveThe aim of this study was to evaluate whether treatment with dabigatran might affect shear-induced thrombi (occlusion time [OT], sec) by the GTT, and to investigate the possibility that the GTT could be useful as a monitoring system for dabigatran. PATIENTS/

methodsThe study population consisted of 50 volunteers and 43 NVAF patients on WF therapy, who were subsequently switched to dabigatran. Using the GTT, the thrombotic status was assessed one day before and 1 month after switching anticoagulation from WF to dabigatran.

resultsThe OT was 524.9 ± 17.0 sec in volunteers whereas that of NVAF patients on WF therapy was 581.7 ± 26.3 sec. The switch from WF to dabigatran significantly prolonged OT (784.5 ± 19.3 sec). One patient on WF therapy and 12 patients on dabigatran therapy were shown to have OT > 900 sec.

conclusionThe GTT could be used to assess the risk of dabigatran-related bleeding complications.

Indexed as

Atrial fibrillationNovel oral anticoagulantsWarfarin

Identifiers

PMID26648789
PMCPMC4672538
OpenAlexW2193584778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.